Q1 2014

Filed May 15, 2014 · 10-Q · 45 days after period end · 0001121781-14-000134

Q1 2014 · 10-Q

Revenue

$19.00K

−88.6% vs Q1 2013

Net Income

-$1.56M

N/M vs Q1 2013

EPS Diluted

-$0.02

N/M vs Q1 2013

Gross Profit-$70,000N/M

Operating Income

Same quarter

Metric	Q1 2014	Q1 2013	Q1 2012	Q1 2011
Revenue	$19.00K	$167.00K	$718.00K	$767.00K
Net Income	-$1.56M	-$1.82M	-$1.01M	-$726.00K
EPS Diluted	-$0.02	-$0.03	-$0.02	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR